Replies to post #99153 on Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

No, I meant that Amgen’s
NEO guy left the company. As Hov noted, Amgen has largely abandoned cell-based therapy approaches in general. A change in direction for them.